Our analysis of human ovarian tumors indicated a higher probability of platinum resistance in patients exhibiting high levels of CEBPB mRNA (TCGA dataset) or C/EBPβ protein (IHC analysis) (Fig. 3a). Here, CEBPB is linked to ovarian neoplasm.